VFA
RGNX icon

Virtus Fund Advisers’s Regenxbio RGNX Stock Holding History

Virtus Fund Advisers’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$407K Buy
+12,251
New +$369K ﹤0.01% 348

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtus Fund Advisers's RGNX Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Regenxbio (RGNX) in Q4 2017: 12,251 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #348 among its holdings.

108 funds tracked by Wall St. Rank hold RGNX as of Q4 2017.

  • Virtus Fund Advisers held 12,251 shares of Regenxbio worth $407K as of Q4 2017.
  • Regenxbio was a new Virtus Fund Advisers position in Q4 2017.
  • Regenxbio made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #348 holding.
  • 108 funds tracked by Wall St. Rank held Regenxbio as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.